Results for tag: "Central Nervous System Malignancies"

Central Nervous System (CNS) Malignancies are a group of cancers that originate in the brain, spinal cord, and other parts of the nervous system. These cancers are typically classified as either primary or secondary, depending on their origin. Primary CNS malignancies are those that originate in the brain or spinal cord, while secondary CNS malignancies are those that originate elsewhere in the body and spread to the CNS. In the context of Hematology, CNS malignancies are a major area of research and treatment. Hematologists are often involved in the diagnosis and treatment of these cancers, as well as in the development of new treatments. Treatment options for CNS malignancies include surgery, radiation therapy, chemotherapy, and targeted therapies. Some companies in the CNS malignancies market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. These companies are involved in the development and marketing of treatments for CNS malignancies, as well as in the research and development of new treatments. Show Less Read more